Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy (POSTHYSTREC)
This study is currently recruiting participants.
Verified May 2013 by University Hospital, Linkoeping
Sponsor:
University Hospital, Linkoeping
Information provided by (Responsible Party):
Preben Kjolhede, University Hospital, Linkoeping
ClinicalTrials.gov Identifier:
NCT01526668
First received: January 27, 2012
Last updated: May 27, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to investigate the effect of four different follow-up strategies on postoperative recovery following vaginal or abdominal hysterectomy for benign conditions. Furthermore the investigators aim to examine associations between preoperative thresholds for pain (thermal and pressure) and postoperative pain and development of chronic pelvic pain after benign hysterectomy.
| Condition | Intervention |
|---|---|
|
Hysterectomy Genital Diseases, Female Pain |
Behavioral: Follow-up strategy Behavioral: No contact after discharge |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | A Randomized Study Comparing Four Different Postoperative Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy |
Resource links provided by NLM:
Further study details as provided by University Hospital, Linkoeping:
Primary Outcome Measures:
- Quality of life [ Time Frame: Six weeks ] [ Designated as safety issue: No ]The Euroqol questionnaire form (EQ-5D) and Short-Form 36 (SF-36) are used for assessing the quality of life. Assessments preoperatively, once daily the first week postoperatively and then once weekly for additional five weeks.
Secondary Outcome Measures:
- Postoperative symptoms [ Time Frame: Six weeks ] [ Designated as safety issue: No ]Selfreported symptoms in the Swedish Postoperative Symptom Questionnaire. Assessments preoperatively, once daily the first week postoperatively and then once weekly for additional five weeks.
- Consumption of analgesic [ Time Frame: Six weeks ] [ Designated as safety issue: No ]Total amount of opioids and non-opioids from surgery to six weeks postoperatively
- Complications related to operation [ Time Frame: Six weeks ] [ Designated as safety issue: No ]From surgery to six weeks postoperatively
- Health economy [ Time Frame: Up to 1 years ] [ Designated as safety issue: No ]Direct and indirect costs, quality adjusted life years (QALYs). From surgery to return to work
- Development of chronic pelvic pain [ Time Frame: One year ] [ Designated as safety issue: No ]Development of chronic pelvic pain one year postoperatively among women with no pelvic pain preoperatively
- Duration of sick-leave [ Time Frame: Up to one year ] [ Designated as safety issue: No ]Time from day of surgery to return to work at same level as preoperatively
| Estimated Enrollment: | 600 |
| Study Start Date: | October 2011 |
| Estimated Study Completion Date: | January 2016 |
| Estimated Primary Completion Date: | October 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: No contact after discharge
In Arm A: The patient do not have planned contacts with the study nurse or doctor after discharge. All patients are seen by the study nurse six weeks postoperatively.
|
Behavioral: No contact after discharge |
|
Active Comparator: Single telephone contact
In Arm B: The patient has one planned telephone contact with the study nurse the day after discharge. All patients are seen by the study nurse six weeks postoperatively.
|
Behavioral: Follow-up strategy
Comparison of different follow-up strategies
|
|
Active Comparator: Telephone contacts regularly
In Arm C: The patient has planned telephone contacts with the study nurse the day after discharge and then once weekly until the six weeks follow-up visit postoperatively.
|
Behavioral: Follow-up strategy
Comparison of different follow-up strategies
|
|
Active Comparator: Telephone contact using CBT-inspired strategy
In Arm C: The patient has planned telephone contacts with the study nurse the day after discharge and then once weekly until the six weeks follow-up visit postoperatively. At these telephone contacts the study nurse uses a cognitive behavior therapy (CBT)-inspired strategy in counselling and support.
|
Behavioral: Follow-up strategy
Comparison of different follow-up strategies
|
Detailed Description:
Contact sponsor if detailed information is requested.
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Women between 18 and 60 years of age.
- Women who are scheduled for vaginal or abdominal total or subtotal hysterectomy for benign gynecological diseases (including cervical dysplasia).
- Women who understand and speak Swedish fluently.
- Women who gives signed informed consent to participate in the study.
- Women who have access to a telephone and/or internet.
Exclusion Criteria:
- Women where the hysterectomy is carried out in association with surgery for genital prolapse
- Women with genital malignancies (does not include cervical dysplasia).
- Women where the operation is planned or expected to comprise more than the hysterectomy with or without unilateral salpingooophorectomy and appendectomy en passant.
- Women with previous bilateral salpingooophorectomy.
- Women who are physically disabled to a degree so that mobilization postoperatively cannot be expected as for a normal individual.
- Women who are mentally disabled to a degree so she cannot complete the forms in the study or understand the tenor of the participation or it is considered doubtful from an ethical point of view to participate.
- Women with psychiatric disease or is on medication for severe psychiatric disease so that the physician consider participation in the study unsuitable.
- Women with current drug or alcohol abuse.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01526668
Contacts
| Contact: Preben Kjolhede, MD, PhD | +46101030000 ext 3187 | Preben.Kjolhede@lio.se |
| Contact: Ninnie Borendal Wodlin, MD, PhD | +46101030000 ext 3133 | Ninnie.Borendal.Wodlin@lio.se |
Locations
| Sweden | |
| Department of Obstetrics and Gynecology, Höglandshospital | Recruiting |
| Eksjo, Jonkopings län, Sweden, 57533 | |
| Contact: Tomasz Stypa, MD +4638135000 Tomasz.Stypa@lj.se | |
| Principal Investigator: Tomasz Stypa, MD | |
| Department of Obstetrics and Gynecology, Ryhov Central Hospital | Recruiting |
| Jonkoping, Jonkopings län, Sweden, 551 85 | |
| Contact: Laila Falknas, MD +4636321000 Laila.Falknas@lj.se | |
| Principal Investigator: Laila Falknas, MD | |
| Department of Obstetrics and Gynecology | Recruiting |
| Varnamo, Jonkopings Län, Sweden, 331 85 | |
| Contact: Christina Gunnervik, MD +46270697000 Christina.Gunnervik@lj.se | |
| Principal Investigator: Christina Gunnervik, MD | |
| Department of Obstetrics and Gynecology, University Hospital | Recruiting |
| Linkoping, Ostergotland, Sweden, 58185 | |
| Contact: Preben Kjolhede, MD, PhD +46101030000 ext 3187 Preben.Kjolhede@lio.se | |
| Contact: Ninnie Borendal Wodlin, MD, PhD +46101030000 ext 3133 Ninnie.Borendal.Wodlin@lio.se | |
| Principal Investigator: Preben Kjolhede, MD, PhD | |
| Sub-Investigator: Ninnie Borendal Wodlin, MD, PhD | |
| Sub-Investigator: Gulnara Kassymova, MD | |
| Sub-Investigator: Peter Lukas, MD | |
| Department of Obstetrics and Gynecology, Vrinnevi Hospital | Recruiting |
| Norrkoping, Ostergotland, Sweden, 60779 | |
| Contact: Leif Hidmark, MD +46101030000 Leif.Hidmark@lio.se | |
| Principal Investigator: Leif Hidmark, MD | |
Sponsors and Collaborators
University Hospital, Linkoeping
Investigators
| Study Chair: | Preben Kjolhede, MD, PhD | Department of Obstetrics and Gynecology, University Hospital, 58185 Linkoping, Sweden |
| Study Chair: | Ninnie Borendal Wodlin, MD, PhD | Department of Obstetrics and Gynecology, University Hospital, S-58185 Linkoping, Sweden |
| Study Chair: | Lena Nilsson, MD, PhD | Department of Anesthesiology, University Hospital, S-58185 Linkoping, Sweden |
| Study Chair: | Gunilla Sydsjo, PhD | Department of Obstetrics and Gynecology, University Hospital, S-58185 Linkoping, Sweden |
| Study Chair: | Gulnara Kassymova, MD | Department of Obstetrics and Gynecology, University Hospital, S-58185 Linkoping, Sweden |
| Study Chair: | Peter Lukas, MD | Department of Obstetrics and Gynecology, University Hospital, S-58185 Linkoping, Sweden |
| Study Chair: | Björn Gerdle, MD, PhD | Pain and Rehabilitation Center, University Hospital, 581 85 Linkoping, Sweden |
More Information
No publications provided
| Responsible Party: | Preben Kjolhede, Professor, University Hospital, Linkoeping |
| ClinicalTrials.gov Identifier: | NCT01526668 History of Changes |
| Other Study ID Numbers: | POSTHYSTREC |
| Study First Received: | January 27, 2012 |
| Last Updated: | May 27, 2013 |
| Health Authority: | Sweden: Regional Ethical Review Board |
Keywords provided by University Hospital, Linkoeping:
|
Benign gynecological disease Surgery Postoperative follow-up strategy Pain threshold Chronic pelvic pain |
[E04.950.300.399] [C13.351.500] [F02.463.593.710.560] [N02.421.585.722.700] Postoperative Care |
Additional relevant MeSH terms:
|
Genital Diseases, Female |
ClinicalTrials.gov processed this record on June 18, 2013